Team:Tokyo-NoKoGen/Safety

From 2011.igem.org

(Difference between revisions)
(Safety)
Line 1: Line 1:
-
<!-- *** What falls between these lines is the Alert Box!  You can remove it from your pages once you have read and understood the alert *** -->
+
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
-
 
+
<html>
<html>
-
<div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
+
<head>
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
+
<meta http-equiv=Content-Type content="text/html; charset=ISO-8859-1">
-
This is a template page. READ THESE INSTRUCTIONS.
+
<title>SAFETY</title>
-
</div>
+
<meta name="viewport" content="width = 960, minimum-scale = 0.25, maximum-scale = 1.60">
-
<div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
+
<meta name="GENERATOR" content="Freeway 5 Express 5.6.0 Trial">
-
You are provided with this team page template with which to start the iGEM season. You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki. You can find some examples <a href="https://2008.igem.org/Help:Template/Examples">HERE</a>.
+
<style type="text/css">
-
</div>
+
<!--
-
<div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
+
body { margin:0px; background-color:#fff; height:100% }
-
You <strong>MUST</strong> have a team description page, a project abstract, a complete project description, a lab notebook, and a safety page. PLEASE keep all of your pages within your teams namespace.
+
html { height:100% }
-
</div>
+
img { margin:0px; border-style:none }
 +
button { margin:0px; border-style:none; padding:0px; background-color:transparent; vertical-align:top }
 +
p:first-child { margin-top:0px }
 +
table { empty-cells:hide }
 +
.f-sp { font-size:1px; visibility:hidden }
 +
.f-lp { margin-bottom:0px }
 +
.f-fp { margin-top:0px }
 +
.f-x1 {  }
 +
.f-x2 {  }
 +
.f-x3 {  }
 +
em { font-style:italic }
 +
h1 { font-size:18px }
 +
h1:first-child { margin-top:0px }
 +
strong { font-weight:bold }
 +
.style27 { color:#000 }
 +
.style15 { font-family:Arial,Helvetica,sans-serif; font-size:20px }
 +
.style28 { color:#000 }
 +
.style16 { color:#000; font-family:Arial,Helvetica,sans-serif; font-weight:bold }
 +
.style17 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style18 { color:#000; font-family:Arial,Helvetica,sans-serif; margin-left:72px; text-indent:-72px }
 +
.style19 { color:#000; font-family:Arial,Helvetica,sans-serif; font-style:italic }
 +
.style20 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style21 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style22 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style23 { color:#000; font-family:Arial,Helvetica,sans-serif }
 +
.style9 { color:#00f94f; font-family:Chalkduster; font-size:70px; text-align:center }
 +
.style1 { text-align:center }
 +
.style6 { color:#000; font-family:Arial,Helvetica,sans-serif; font-size:14px }
 +
.style5 { color:#97238d }
 +
#fwNav1 { float:right;  padding:0; margin:0; list-style:none; }
 +
#fwNav1 .fwNavItem { width:auto;  float:left;margin:0; padding:0; border-right:1px Solid #0E0F10; border-top:0; border-bottom:0; border-left:1px Solid #647B86; position:relative; }
 +
#fwNav1 .fwNavItem a { display:block;color:#FFFFFF; text-decoration:none; background:url(Resources/transparent.gif) repeat; margin:0;padding:3px 10px 3px 10px; height:1%; }
 +
#fwNav1 .fwFirstChild { border-left:0; }
 +
#fwNav1 .fwLastChild { border-right:0; }
 +
#fwNav1 .fwNavItem a:hover, #fwNav1 .fwNavItem span a:hover, #fwNav1 .fwNavItem a:focus { color:#437286; text-decoration:none; background:url(Resources/transparent.gif) repeat; }
 +
#fwNav1 .fwNavItem a:active { text-decoration:none; background:url(Resources/transparent.gif) repeat; }
 +
#fwNav1 .fwNavItem a.fwCurrent, #fwNav1 .fwNavItem a.fwCurrent:hover { display:block; color:#839FAD; background:url(Resources/transparent.gif) repeat; }
 +
* html #fwNav1 { float:right; }
 +
* html #fwNav1 .fwNavItem a { float:left; height:1%; }
 +
-->
 +
</style>
 +
<!--[if lt IE 7]>
 +
<link rel=stylesheet type="text/css" href="css/ie6.css">
 +
<![endif]-->
 +
<script src="Resources/FW_Object.js" type="text/javascript"></script>
 +
</head>
 +
<body>
 +
<div id="PageDiv" style="position:relative; min-height:100%">
 +
<table border=0 cellspacing=0 cellpadding=0 width=896>
 +
<colgroup>
 +
<col width=37>
 +
<col width=858>
 +
<col width=1>
 +
</colgroup>
 +
<tr valign=top>
 +
<td height=10 colspan=2></td>
 +
<td height=10></td>
 +
</tr>
 +
<tr valign=top>
 +
<td height=24></td>
 +
<td height=24>
 +
<div style="width:858px; position:relative; z-index:1; overflow:visible">
 +
<div class="fwNavContainer1">
 +
<ul class="style1 f-fp f-lp" id="fwNav1">
 +
<li class="fwFirstChild fwNavItem"><a href="index.html"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">HOME</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Team"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">TEAM</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Project"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">PROJECT</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Parts"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">PARTS</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Notebook"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">NOTEBOOK</span></strong></span></a></li>
 +
<li class="fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Safety"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">SAFETY</span></strong></span></a></li>
 +
<li class="fwLastChild fwNavItem"><a href="https://2011.igem.org/Team:Tokyo-NoKoGen/Sponsors"><span class="style6" style="text-decoration:none"><strong><span class="style5" style="text-decoration:none">SPONSOR</span></strong></span></a></li>
 +
</ul>
 +
</div>
 +
</div>
 +
</td>
 +
<td height=24></td>
 +
</tr>
 +
<tr class="f-sp">
 +
<td><img src="Resources/_clear.gif" border=0 width=37 height=1 alt="" style="float:left"></td>
 +
<td><img src="Resources/_clear.gif" border=0 width=858 height=1 alt="" style="float:left"></td>
 +
<td height=1><img src="Resources/_clear.gif" border=0 width=1 height=1 alt="" style="float:left"></td>
 +
</tr>
 +
</table>
 +
<table border=0 cellspacing=0 cellpadding=0 width=961>
 +
<colgroup>
 +
<col width=960>
 +
<col width=1>
 +
</colgroup>
 +
<tr valign=top>
 +
<td height=126 bgcolor="#ffffff"><p class="style9 f-lp">Tokyo-NokoGen 2011</p>
 +
</td>
 +
<td height=126></td>
 +
</tr>
 +
<tr class="f-sp">
 +
<td><img src="Resources/_clear.gif" border=0 width=960 height=1 alt="" style="float:left"></td>
 +
<td height=8><img src="Resources/_clear.gif" border=0 width=1 height=1 alt="" style="float:left"></td>
 +
</tr>
 +
</table>
 +
<table border=0 cellspacing=0 cellpadding=0 width=938>
 +
<colgroup>
 +
<col width=11>
 +
<col width=926>
 +
<col width=1>
 +
</colgroup>
 +
<tr valign=top>
 +
<td height=933></td>
 +
<td height=933><p><span class="style27"><strong><span class="style15">&lt;Safety Proposal&gt;</span></strong></span></p>
 +
<p><span class="style16">-Would any of your project ideas raise safety issues in terms of:&nbsp;</span></p>
 +
<p class="style18"> &#9642; researcher safety,</p>
 +
<p class="style18"> &#9642; public safety, or</p>
 +
<p class="style18"> &#9642; environmental safety?</p>
 +
<p><span class="style19">&nbsp;&nbsp;Our project will not raise any issues in researcher safety, public safety and environmental safety. Our project will be carried out with E. coli</span><span class="style20"> laboratory strains and we do not use any infectious organisms. Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor) and Prof. Ikebukuro (instructor). Those laboratories have a proper facility of the biosafety level 2 to handle </span><span class="style19">E. coli</span><span class="style20"> and perform genetic engineering experiments.</span></p>
 +
<p><span class="style20">&nbsp; In our project, we are trying to construct the </span><span class="style19">E. coli</span><span class="style20"> that absorbs Cesium from radioactive-contaminated water. The ultimate aim of our project is to develop an </span><span class="style19">E. coli</span><span class="style20"> machine that can be practically used to clean up radioactive-contaminated environment. However, genetically engineered organisms cannot be easily released to environment. All team members well understand this point. We are just aiming as biotechnologists at showing potential of synthetic biology for those applications that are harmful for humans and cannot be easily achieved by non-biological ways.</span></p>
 +
<p>&nbsp;</p>
 +
<p><span class="style16">-Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,&nbsp;</span></p>
 +
<p class="style18"> &#9642; did you document these issues in the Registry?</p>
 +
<p class="style18"> &#9642; how did you manage to handle the safety issue?</p>
 +
<p class="style18"> &#9642; How could other teams learn from your experience?</p>
 +
<p><span class="style22">&nbsp;&nbsp; No,they don&#8217;t.&nbsp;Our BioBrick parts do not posess any safety risk for environment and researches. We will make a new BioBrick part that uptakes cesium from environment. This part is natively expressed in a non-harmful strain of E. coli and we will clone it from that strain. We are also trying to make new BioBrick parts to regulate gene expressing network.&nbsp;We will use those genes that already have analyzed in peer-reviewed papers.&nbsp;Thus that new BioBrick part will not raise any safety issues.&nbsp;</span></p>
 +
<p>&nbsp;</p>
 +
<p><span class="style16">-Is there a local biosafety group, committee, or review board at your institution?</span></p>
 +
<p class="style18"> &#9642; If yes, what does your local biosafety group think about your project?</p>
 +
<p class="style18"> &#9642; If no, which specific biosafety rules or guidelines do you have to consider in your country?</p>
 +
<p><span class="style22">&nbsp;&nbsp; Yes, there is. There is the committee of Tokyo University of Agriculture and Technology, and we are following its safety and ethical guidelines.</span></p>
 +
<p>&nbsp;</p>
 +
<p><span class="style16">-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</span></p>
 +
<p class="f-lp"><span class="style22">&nbsp;&nbsp; Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury.&nbsp;So, minimizing the number of no­injury accidents will reduce the probability of more severe accidents.&nbsp;We suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. That should prevent the occurrence of more serious hazards.</span></p>
 +
</td>
 +
<td height=933></td>
 +
</tr>
 +
<tr class="f-sp">
 +
<td><img src="Resources/_clear.gif" border=0 width=11 height=1 alt="" style="float:left"></td>
 +
<td><img src="Resources/_clear.gif" border=0 width=926 height=1 alt="" style="float:left"></td>
 +
<td height=1><img src="Resources/_clear.gif" border=0 width=1 height=1 alt="" style="float:left"></td>
 +
</tr>
 +
</table>
</div>
</div>
 +
</body>
</html>
</html>
-
 
-
<!-- *** End of the alert box *** -->
 
-
 
-
 
-
 
-
{|align="justify"
 
-
|You can write a background of your team here.  Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
 
-
|[[Image:Tokyo-NoKoGen_logo.png|200px|right|frame]]
 
-
|-
 
-
|
 
-
''Tell us more about your project.  Give us background.  Use this is the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
 
-
|[[Image:Tokyo-NoKoGen_team.png|right|frame|Your team picture]]
 
-
|-
 
-
|
 
-
|align="center"|[[Team:Tokyo-NoKoGen | Team Example]]
 
-
|}
 
-
 
-
<!--- The Mission, Experiments --->
 
-
 
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
 
-
!align="center"|[[Team:Tokyo-NoKoGen|Home]]
 
-
!align="center"|[[Team:Tokyo-NoKoGen/Team|Team]]
 
-
!align="center"|[https://igem.org/Team.cgi?year=2010&team_name=Tokyo-NoKoGen Official Team Profile]
 
-
!align="center"|[[Team:Tokyo-NoKoGen/Project|Project]]
 
-
!align="center"|[[Team:Tokyo-NoKoGen/Parts|Parts Submitted to the Registry]]
 
-
!align="center"|[[Team:Tokyo-NoKoGen/Modeling|Modeling]]
 
-
!align="center"|[[Team:Tokyo-NoKoGen/Notebook|Notebook]]
 
-
!align="center"|[[Team:Tokyo-NoKoGen/Safety|Safety]]
 
-
!align="center"|[[Team:Tokyo-NoKoGen/Attributions|Attributions]]
 
-
|}
 
-
 
-
 
-
==Safety==
 
-
 
-
Please use this page to answer the safety questions posed on the [[Safety | safety page]].
 
-
<div><span style="font-size:large">&lt;Safety Proposal&gt;</span></div>
 
-
<div>
 
-
<div><span style="line-height:19px;font-family:sans-serif;color:rgb(0,0,0)"><span style="font-size:large">
 
-
</span>
 
-
<table border="0" style="background-color:white;color:black;font-size:13px">
 
-
<td bgcolor="#ffff99" valign="top"><b><span style="font-size:medium">-Would any of your project ideas raise safety issues in terms of:&nbsp;</span></b><span style="font-size:medium"><br>
 
-
</span>
 
-
<ol style="padding-bottom:0px;line-height:1.5em;margin:0.3em 0px 0px 3.2em;padding-left:0px;padding-right:0px;padding-top:0px">
 
-
<ul style="padding-bottom:0px;line-height:1.5em;list-style-type:square;margin:0.3em 0px 0px 1.5em;padding-left:0px;padding-right:0px;padding-top:0px">
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">researcher safety,</span></li>
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">public safety, or</span></li>
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">environmental safety?</span></li></ul>
 
-
</ol>
 
-
<div>
 
-
<p><span><span style="font-size:medium">&nbsp;&nbsp;</span></span><span style="font-size:medium">Our project will not raise any issues in researcher safety, public safety and environmental safety. Our project will be carried out with </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> laboratory strains and we do not use any infectious organisms. Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor) and Prof. Ikebukuro (instructor). Those laboratories have a proper facility of the biosafety level 2 to handle </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> and perform genetic engineering experiments.</span></p>
 
-
</div>
 
-
<p><span><span style="font-size:medium">&nbsp; </span></span><span style="font-size:medium">In our project, we are trying to construct the </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> that absorbs Cesium from radioactive-contaminated water. The ultimate aim of our project is to develop an </span><i><span style="font-size:medium">E. coli</span></i><span style="font-size:medium"> machine that can be practically used to clean up radioactive-contaminated environment. However, genetically engineered organisms cannot be easily released to environment. All team members well understand this point. We are just aiming as biotechnologists at showing potential of synthetic biology for those applications that are harmful for humans and cannot be easily achieved by non-biological ways.</span></p>
 
-
<div><span style="font-size:medium"><br>
 
-
</span></div>
 
-
<b><span style="font-size:medium">-Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,&nbsp;</span></b><span style="font-size:medium"><br>
 
-
</span>
 
-
<ol style="padding-bottom:0px;line-height:1.5em;margin:0.3em 0px 0px 3.2em;padding-left:0px;padding-right:0px;padding-top:0px">
 
-
<ul style="padding-bottom:0px;line-height:1.5em;list-style-type:square;margin:0.3em 0px 0px 1.5em;padding-left:0px;padding-right:0px;padding-top:0px">
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">did you document these issues in the Registry?</span></li>
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">how did you manage to handle the safety issue?</span></li>
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">How could other teams learn from your experience?</span></li></ul>
 
-
</ol>
 
-
<div>
 
-
<p><span style="font-size:medium">&nbsp;&nbsp; No,they don’t.&nbsp;Our BioBrick parts do not posess any safety risk for environment and researches. We will make a new BioBrick part that uptakes cesium from environment. This part is natively expressed in a non-harmful strain of E. coli and we will clone it from that strain. We are also trying to make new BioBrick parts to regulate gene expressing network.&nbsp;We will use those genes that already have analyzed in peer-reviewed papers.&nbsp;Thus that new BioBrick part will not raise any safety issues.&nbsp;</span></p>
 
-
</div>
 
-
<div><span style="font-size:medium"><br>
 
-
</span></div>
 
-
<b><span style="font-size:medium">-Is there a local biosafety group, committee, or review board at your institution?</span></b><span style="font-size:medium"><br>
 
-
</span>
 
-
<ol style="padding-bottom:0px;line-height:1.5em;margin:0.3em 0px 0px 3.2em;padding-left:0px;padding-right:0px;padding-top:0px">
 
-
<ul style="padding-bottom:0px;line-height:1.5em;list-style-type:square;margin:0.3em 0px 0px 1.5em;padding-left:0px;padding-right:0px;padding-top:0px">
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">If yes, what does your local biosafety group think about your project?</span></li>
 
-
<li style="margin-bottom:0.1em"><span style="font-size:medium">If no, which specific biosafety rules or guidelines do you have to consider in your country?</span></li></ul>
 
-
</ol>
 
-
<div>
 
-
 
-
<p><span style="font-size:medium">&nbsp;&nbsp; Yes, there is. There is the committee of Tokyo University of
 
-
Agriculture and Technology, and we are following its safety and ethical guidelines.</span></p>
 
-
 
-
</div>
 
-
<div><span style="font-size:medium"><br>
 
-
</span></div>
 
-
<b><span style="font-size:medium">-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</span></b><span style="font-size:medium"><br>
 
-
</span>
 
-
<p><span lang="EN-US"><span style="font-size:medium">&nbsp;&nbsp; Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury.&nbsp;</span></span><span style="font-size:medium">So, minimizing the number of no­injury accidents will reduce the probability of more severe accidents.&nbsp;We suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. That should prevent the occurrence of more serious hazards.</span></p>
 
-
</td>
 
-
</table>
 
-
</span></div>
 
-
</div>
 

Revision as of 15:05, 25 August 2011

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> SAFETY

Tokyo-NokoGen 2011

<Safety Proposal>

-Would any of your project ideas raise safety issues in terms of: 

▪ researcher safety,

▪ public safety, or

▪ environmental safety?

  Our project will not raise any issues in researcher safety, public safety and environmental safety. Our project will be carried out with E. coli laboratory strains and we do not use any infectious organisms. Our laboratory work will be carried out in the laboratories of Prof. Sode (advisor), Assoc. Prof. Tsugawa (instructor) and Prof. Ikebukuro (instructor). Those laboratories have a proper facility of the biosafety level 2 to handle E. coli and perform genetic engineering experiments.

  In our project, we are trying to construct the E. coli that absorbs Cesium from radioactive-contaminated water. The ultimate aim of our project is to develop an E. coli machine that can be practically used to clean up radioactive-contaminated environment. However, genetically engineered organisms cannot be easily released to environment. All team members well understand this point. We are just aiming as biotechnologists at showing potential of synthetic biology for those applications that are harmful for humans and cannot be easily achieved by non-biological ways.

 

-Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes, 

▪ did you document these issues in the Registry?

▪ how did you manage to handle the safety issue?

▪ How could other teams learn from your experience?

   No,they don’t. Our BioBrick parts do not posess any safety risk for environment and researches. We will make a new BioBrick part that uptakes cesium from environment. This part is natively expressed in a non-harmful strain of E. coli and we will clone it from that strain. We are also trying to make new BioBrick parts to regulate gene expressing network. We will use those genes that already have analyzed in peer-reviewed papers. Thus that new BioBrick part will not raise any safety issues. 

 

-Is there a local biosafety group, committee, or review board at your institution?

▪ If yes, what does your local biosafety group think about your project?

▪ If no, which specific biosafety rules or guidelines do you have to consider in your country?

   Yes, there is. There is the committee of Tokyo University of Agriculture and Technology, and we are following its safety and ethical guidelines.

 

-Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?

   Heinrich's Law: for every 300 unsafe acts (no-injury accidents), there are 29 minor injuries and 1 major injury. So, minimizing the number of no­injury accidents will reduce the probability of more severe accidents. We suggest that all teams share any safety issues and solution timely on iGEM web site or wikis. That should prevent the occurrence of more serious hazards.